EU-JAMRAI 2 launch in Paris unveils next chapter in Europe's unified response to antimicrobial resistance
After the success of the first edition of EU-JAMRAI, 120 organizations from 30 countries converge to fight antimicrobial resistance, amplifying Europe's response to a pressing public health crisis.
The European Commission, policymakers and organizations from 30 countries are convening in Paris on the 13th of February 2024 to launch the second Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI 2). Coordinated by Inserm (National Institute of Health and Medical Research), France, with the support of the French Ministry of Health, this collaborative venture aims to more effectively combat antimicrobial resistance: a major public health threat responsible for more than 35,000 deaths each year in the European Union (EU)/European Economic Area (EEA) and 1.3 million people worldwide.
On behalf of Hungary, NCPHP acts as a competent authority in the 4-year EU JAMRAI 2 Joint Action, one of the most significant European collaborations supporting concerted against antimicrobial resistance (AMR) and healthcare-associated infections. The Hungarian participation involves several working groups in both human health and environmental health. The objectives include the development of a framework to support the appropriate use of antimicrobials through antimicrobial stewardship (AMS) guidance and professional collaboration in human health, furthermore the identification of behavioural barriers to appropriate antimicrobial prescribing and infection control practices and the development of interventions to influence behaviour. In the field of environmental health, the aim is to establish an environmental AMR surveillance system based on common methology and to develop a training programme to raise awareness of the problem of environmental AMR emissions and the possibilities for reduction among relevant professionals. A communication campaign is also planned to raise public awareness of AMR.
